Use of Intracoronary Imaging for Optimization of Bioresorbable Vascular Scaffold Implantation and Left Main Disease.
作者信息
Tam Weng Chio, Lam U Po, Ho Wa, De Brito Lima Evora Mario Alberto
机构信息
Department of Cardiology, Centro Hospitalar Conde São Januário, Macau SAR.
出版信息
Acta Cardiol Sin. 2019 Jul;35(4):437-438. doi: 10.6515/ACS.201907_35(4).20190306A.
Abstract
摘要
相似文献
1
Use of Intracoronary Imaging for Optimization of Bioresorbable Vascular Scaffold Implantation and Left Main Disease.
Acta Cardiol Sin. 2019 Jul;35(4):437-438. doi: 10.6515/ACS.201907_35(4).20190306A.
2
Optical coherence tomography guidance during bioresorbable vascular scaffold implantation.
J Thorac Dis. 2017 Aug;9(Suppl 9):S986-S993. doi: 10.21037/jtd.2017.07.111.
3
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.
Lancet. 2016 Nov 19;388(10059):2479-2491. doi: 10.1016/S0140-6736(16)32050-5. Epub 2016 Oct 30.
4
Prevalence of parameters of suboptimal scaffold deployment following angiographic guided bioresorbable vascular scaffold implantation in real world practice - an optical coherence tomography analysis.
Int J Cardiol. 2016 Oct 1;220:32-42. doi: 10.1016/j.ijcard.2016.06.096. Epub 2016 Jun 23.
5
Randomized Comparison of Absorb Bioresorbable Vascular Scaffold and Mirage Microfiber Sirolimus-Eluting Scaffold Using Multimodality Imaging.
JACC Cardiovasc Interv. 2017 Jun 12;10(11):1115-1130. doi: 10.1016/j.jcin.2017.03.015. Epub 2017 May 17.
6
The Importance of Intravascular Image for Left Main Coronary Artery Disease and Bioresorbable Vascular Scaffold Implantation.
Acta Cardiol Sin. 2019 Jul;35(4):439-440. doi: 10.6515/ACS.201907_35(4).20190423A.
7
"The Unpredictable ABSORB" - Very Late Stent Thrombosis of Bioresorbable Vascular Scaffold.
Heart Views. 2019 Apr-Jun;20(2):65-69. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_18_19.
8
Absorb bioresorbable vascular scaffold: What have we learned after 5 years of clinical experience?
Int J Cardiol. 2015 Dec 15;201:129-36. doi: 10.1016/j.ijcard.2015.07.101. Epub 2015 Aug 7.
9
Optimisation of percutaneous coronary intervention: indispensables for bioresorbable scaffolds.
Expert Rev Cardiovasc Ther. 2016 Sep;14(9):1053-70. doi: 10.1080/14779072.2016.1208084. Epub 2016 Jul 14.
10
Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.
Lancet. 2016 Feb 6;387(10018):537-544. doi: 10.1016/S0140-6736(15)00979-4. Epub 2015 Nov 17.
本文引用的文献
1
Percutaneous Coronary Intervention for Tortuous Left Anterior Descending Artery with Bioresorbable Vascular Scaffold via the Transradial Approach.
Acta Cardiol Sin. 2018 Nov;34(6):530-532. doi: 10.6515/ACS.201811_34(6).20180818B.
2
Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions.
Eur Heart J. 2018 Sep 14;39(35):3281-3300. doi: 10.1093/eurheartj/ehy285.
3
Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients.
JACC Cardiovasc Interv. 2017 Dec 26;10(24):2488-2498. doi: 10.1016/j.jcin.2017.08.051. Epub 2017 Nov 15.
4
Mechanisms of Very Late Bioresorbable Scaffold Thrombosis: The INVEST Registry.
J Am Coll Cardiol. 2017 Nov 7;70(19):2330-2344. doi: 10.1016/j.jacc.2017.09.014.
5
Percutaneous coronary intervention in left main coronary artery disease with or without intravascular ultrasound: A meta-analysis.
PLoS One. 2017 Jun 22;12(6):e0179756. doi: 10.1371/journal.pone.0179756. eCollection 2017.
6
Concise Review of Optical Coherence Tomography in Clinical Practice.
Acta Cardiol Sin. 2016 Jul;32(4):381-6. doi: 10.6515/acs20151026a.
7
2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
Eur Heart J. 2014 Oct 1;35(37):2541-619. doi: 10.1093/eurheartj/ehu278. Epub 2014 Aug 29.
Zotero 插件